Bioresorbable Airway Splint Pivotal Clinical Trial

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

September 30, 2029

Study Completion Date

March 31, 2034

Conditions
Tracheobronchomalacia
Interventions
DEVICE

Bioresorbable Tracheobronchial Splint

"Subjects will have several imaging and bronchoscopic studies and the placement of the splint will require an open-chest surgery to implant the airway splint (s).~The Materialise Bioresorbable Tracheobronchial Splint is designed for an individual subject based on Computed Tomography (CT) scans taken using a specific scan protocol. Based on these 3D models, a pre-operative plan is discussed between the Materialise engineering team and the treating surgeon(s) to determine the locations and required dimensions of the splint(s). Each subject may receive up to four splints positioned on subject's trachea or mainstem bronchi.~Subjects will also have several follow-up visits, and parents will be expected to regularly fill out questionnaires."

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Materialise

INDUSTRY

lead

University of Michigan

OTHER